Private Capital Advisors, Inc.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1350780
DARIEN, CT
Position in REGN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$218,239
-$52,185 QoQ
Shares Held
350
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,027
of 1,322 holders
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Private Capital Advisors, Inc. holds $1,338,094 across 5 Biotechnology names. REGN ranks #5 (16.3% of the industry book) .
All Filings in REGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $218,239 | 350 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $270,424 | 350 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $270,154 | 350 | Shares | Sole | 2026-02-09 | |
| 2025-06-30 | $323,400 | 616 | Shares | Sole | 2025-07-30 | |
| No filing history on record for this holder in this stock. | ||||||